Latest National Institute of Child Health and Human Development Stories
- Niemann-Pick Disease experts Drs. Paul Gissen, Marc Patterson and Forbes D. Porter, along with biopharmaceutical industry leader Dr.
CINCINNATI, March 24, 2015 /PRNewswire-USNewswire/ -- Cincinnati Children's Hospital Medical Center is receiving a $2.2 million award to develop and maintain a sophisticated national data resource.
Health Decisions Will Support Infectious Disease Clinical Trials as a DynPort Vaccine Company Teaming Partner on a National Institute of Allergy and Infectious Diseases Program to Evaluate Anti-Infective
March of Dimes Honors Abstract on Prematurity at SMFM Meeting SAN DIEGO, Feb.
More than 140,000 U.S. births now supported by electronic fetal monitoring and surveillance technology CRANBURY, N.J., Jan.
- Vtesse to collaborate with National Institutes of Health on development of VTS-270 for Niemann-Pick Disease Type C and other novel drugs for life-threatening rare diseases GAITHERSBURG,
Noted Scientist Is Recognized For a Career Devoted to Furthering Knowledge of Fetal-Maternal Nutrition NEW ORLEANS, Nov.
The Effects of Aspirin in Gestation and Reproduction (EAGeR) medical trial has found that, in general, low-dose aspirin is not beneficial for future pregnancy outcomes in women with prior pregnancy loss.
Leading researchers and global health organizations today issued a call-to-action to advance a comprehensive research agenda to address the global burden of preterm birth, which has become the leading cause of newborn deaths worldwide.
- Growing in low tufty patches.